Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study (Q37205638)
Jump to navigation
Jump to search
scientific article published on June 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study |
scientific article published on June 2016 |
Statements
1 reference
Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study (English)
1 reference
Toshifumi Hibi
1 reference
Shunsei Hirohata
1 reference
Hirotoshi Kikuchi
1 reference
Ukihide Tateishi
1 reference
Noriko Sato
1 reference
Kunihiko Ozaki
1 reference
Kazuoki Kondo
1 reference
Yoshiaki Ishigatsubo
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference